Israel-based alt-protein company MeaTech 3D has begun research and development activities around cultivated pork, the company announced today.
Initial activities will focus largely on developing porcine cell lines, which the company says could expand its number of potential addressable markets since pork is the most widely consumed meat in the world. The porcine cell lines will add to MeaTech’s existing cell ag efforts, including cell lines for beef and chicken.
In May of this year, the company announced plans for a pilot production facility that will first be used to increase the production of its cultured fat product and then go on to produce entire cuts of cultivated meat using the company’s 3D bioprinting technology.
Cell lines are a crucial step in the process of making cultivated meat, since cells are the starting inputs for any eventual product. However, creating new cell lines is an expensive and time-consuming process, and researchers are still figuring out which types of cells are best suited for the kind of large-scale manufacturing most cultured meat companies are aspiring to eventually do.
Most of those companies so far have stuck to developing cultured beef or chicken products, not pork. Despite the latter being the world’s most most popular meat, a very small handful of companies is actually focused on that particular protein right now. Future Meat Technologies, also based in Israel, says its newly opened production facility is producing cultured pork. Dutch startup Meatable, New Age Meats, and Higher Steaks have also done pork prototypes during the last few years.
MeaTech’s specific focus on cell line development will further set it apart from the masses as more companies announce plans to explore cultured pork products in the future.
